Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Subject Collections
    • JASN Podcasts
    • Archives
    • Saved Searches
    • ASN Meeting Abstracts
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Subscriptions
  • More
    • About JASN
    • Alerts
    • Advertising
    • Editorial Fellowship Program
    • Feedback
    • Reprints
    • Impact Factor
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
UP FRONT MATTERSEditorials
You have accessRestricted Access

Management of Symptomatic Carotid Stenosis in Individuals with CKD

Rebecca F. Gottesman and Stephen M. Sozio
JASN January 2010, 21 (1) 9-11; DOI: https://doi.org/10.1681/ASN.2009111126
Rebecca F. Gottesman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Sozio
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

Despite recent interest in carotid stenting for treatment of carotid stenosis, carotid endarterectomy remains the standard of care, particularly for individuals with symptoms referable to that carotid and with moderate to severe stenosis. Interest in stenting has increased in individuals with more medical comorbidities, including renal disease, despite lack of clear data contraindicating endarterectomy in these patients.

The article by Mathew et al. in this issue of JASN1 analyzes existing data from the North American Symptomatic Carotid Endarterectomy trial (NASCET),2 the only large randomized carotid endarterectomy trial in which creatinine levels were routinely measured. The authors show that carotid endarterectomy not only may benefit individuals with symptomatic carotid stenosis and chronic kidney disease (CKD) but also is safe and without major operative complications. In their analysis, the number needed to treat to prevent one stroke among individuals with CKD was only four, compared with 10 among individuals without CKD.

The primary reason for the results in this article, strongly supportive of carotid endarterectomy in symptomatic patients, is that individuals who have GFR <30 ml/min per 1.73 m2 with symptomatic high-grade carotid stenosis (≥70%) and are treated medically have much higher rates of stroke, myocardial infarction, or death than do their equivalents with a normal GFR. In contrast, the risks associated with the surgical group were not elevated to the same extent; in fact, the perioperative stroke or death rate is lower among individuals with CKD than among individuals without CKD. Their results emphasize the poor outcomes among individuals who have CKD and do not undergo revascularization of high-grade carotid stenosis. Individuals who had CKD and were randomly assigned to the surgical treatment group did, however, have significantly higher rates of the composite adverse event of myocardial infarction, congestive heart failure, and arrhythmia (adjusted relative risk 3.98).

In general, the subgroups who have had the least clear benefit from endarterectomy are those with higher rates of surgical complications. Women tend to have higher surgical complication rates than do men and in the NASCET trial do not have as much benefit for treating stenoses <70%.3 As a result, surgery for symptomatic carotid stenosis has maximum benefit among men, individuals who are aged ≥75 yr, and individuals who are treated within 2 wk of a minor stroke or transient ischemic attack.4

Because the NASCET is a randomized trial in which kidney function was not taken into account upon enrollment and the study is now being subjected to a subgroup analysis, there still may be unmeasured confounders that could exist in the relationship between kidney function and outcomes after endarterectomy. Individuals with CKD are likely to have significant small vessel disease of the brain,5,6 and it is possible that individuals with more extensive cerebral small vessel disease and symptomatic carotid stenosis mat be at higher risk for stroke. Among individuals with asymptomatic carotid stenosis, silent infarcts associate with higher risk for stroke.7 In addition, more extensive white matter disease of the brain associates with worse outcome after stroke8 and may be a predictor of having a stroke in general. The other major consideration in management decisions of individuals with carotid stenosis is that primary carotid endarterectomy trials were conducted in an era before routine statin use; it is likely that the same studies done in the current climate would reveal lower rates of stroke in individuals in both treatment groups as a result of the use of statins. Optimal medical management differs in the current era when compared with the era when these large carotid surgery trials were conducted.

It should be emphasized that these results should not be automatically applied to individuals who do not have symptoms and are found to have carotid stenosis, including those found as part of routine clinical care or as part of a transplant evaluation. In a pooled analysis of the asymptomatic carotid stenosis trials, the net relative risk reduction was 0.71 among individuals with >60% stenosis but without symptoms9; however, perioperative complication rates in these trials were particularly low. Because perioperative complications are likely to increase in individuals with more comorbidities and because risk for ischemic stroke is lower in the setting of asymptomatic carotid stenosis, it is less clear that a benefit would still favor surgery for patients with CKD and asymptomatic carotid stenosis. In addition, although this study included patients with advanced CKD and a GFR <30 ml/min per 1.73 m2, the results cannot be extrapolated to those with even more severe stages, including ESRD.

Diagnosis of carotid stenosis is another important consideration for future research; although iodinated dye is required for the stenting procedure itself, confirmation of stenosis often requires either gadolinium (for magnetic resonance angiography) or iodinated dye (for computed tomographic angiography or conventional angiography). Much has been written about the risks of both iodinated contrast and gadolinium contrast in patients with CKD.10,11 Depending on the clinical situation, some surgeons will operate on the basis of carotid ultrasound results alone, but sensitivity and specificity of the diagnosis (as compared with conventional angiography as the gold standard) both increase when carotid duplex is combined with another study, such as magnetic resonance angiography.12

That individuals with CKD in the NASCET trial, particularly those with high-grade stenosis, had such a benefit from carotid endarterectomy in this subgroup analysis will change clinical recommendations for individuals with CKD and symptomatic carotid disease. Recent recommendations have included consideration of carotid endarterectomy in only some cases with CKD,13 but this article emphasizes that it should be considered more routinely, particularly in individuals with >70% stenosis. This is even more important given recent findings that individuals with CKD may have worse outcomes after carotid artery stenting.14

Individuals who have symptomatic moderate- to high-grade carotid stenosis and also have CKD benefit from and tolerate carotid endarterectomy. How this compares with the use of carotid stenting or with the use of maximal medical therapy in an era of statin use and good BP management is still unclear and warrants further study.

Disclosures

None.

Footnotes

  • Published online ahead of print. Publication date available at www.jasn.org.

  • See related article, “Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis,” on pages 145–152.

  • Copyright © 2010 by the American Society of Nephrology

References

  1. 1.↵
    1. Mathew A,
    2. Eliasziw M,
    3. Devereauz PJ,
    4. Merino JG,
    5. Barnett HJM,
    6. Garg AX
    : Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis. J Am Soc Nephrol 21: 145–152, 2010
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Barnett HJ,
    2. Taylor DW,
    3. Eliasziw M,
    4. Fox AJ,
    5. Ferguson GG,
    6. Haynes RB,
    7. Rankin RN,
    8. Clagett GP,
    9. Hachinski VC,
    10. Sackett DL,
    11. Thorpe KE,
    12. Meldrum HE,
    13. Spence JD
    : Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial collaborators. N Engl J Med 339: 1415–1425, 1998
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Rothwell PM,
    2. Eliasziw M,
    3. Gutnikov SA,
    4. Warlow CP,
    5. Barnett HJ
    : Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 35: 2855–2861, 2004
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Rothwell PM,
    2. Eliasziw M,
    3. Gutnikov SA,
    4. Warlow CP,
    5. Barnett HJ
    : Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363: 915–924, 2004
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Ikram MA,
    2. Vernooij MW,
    3. Hofman A,
    4. Niessen WJ,
    5. van der Lugt A,
    6. Breteler MM
    : Kidney function is related to cerebral small vessel disease. Stroke 39: 55–61, 2008
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Wada M,
    2. Nagasawa H,
    3. Iseki C,
    4. Takahashi Y,
    5. Sato H,
    6. Arawaka S,
    7. Kawanami T,
    8. Kurita K,
    9. Daimon M,
    10. Kato T
    : Cerebral small vessel disease and chronic kidney disease (CKD): Results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 272: 36–42, 2008
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Kakkos SK,
    2. Sabetai M,
    3. Tegos T,
    4. Stevens J,
    5. Thomas D,
    6. Griffin M,
    7. Geroulakos G,
    8. Nicolaides AN
    Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group: Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis. J Vasc Surg 49: 902–909, 2009
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Kissela B,
    2. Lindsell CJ,
    3. Kleindorfer D,
    4. Alwell K,
    5. Moomaw CJ,
    6. Woo D,
    7. Flaherty ML,
    8. Air E,
    9. Broderick J,
    10. Tsevat J
    : Clinical prediction of functional outcome after ischemic stroke: The surprising importance of periventricular white matter disease and race. Stroke 40: 530–536, 2009
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Chambers BR,
    2. Donnan GA
    : Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev (19): CD001923, 2005
  10. 10.↵
    1. Goldfarb S,
    2. McCullough PA,
    3. McDermott J,
    4. Gay SB
    : Contrast-induced acute kidney injury: Specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 84: 170–179, 2009
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Swaminathan S,
    2. Shah SV
    : New insights into nephrogenic systemic fibrosis. J Am Soc Nephrol 18: 2636–2643, 2007
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Nederkoorn PJ,
    2. Mali WP,
    3. Eikelboom BC,
    4. Elgersma OE,
    5. Buskens E,
    6. Hunink MG,
    7. Kappelle LJ,
    8. Buijs PC,
    9. Wust AF,
    10. van der Lugt A,
    11. van der Graaf Y
    : Preoperative diagnosis of carotid artery stenosis: Accuracy of noninvasive testing. Stroke 33: 2003–2008, 2002
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Khella SL
    : New insights into stroke in chronic kidney disease. Adv Chronic Kidney Dis 15: 338–346, 2008
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Jackson BM,
    2. English SJ,
    3. Fairman RM,
    4. Karmacharya J,
    5. Carpenter JP,
    6. Woo EY
    : Carotid artery stenting: Identification of risk factors for poor outcomes. J Vasc Surg 48: 74–79, 2008
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 21 (1)
Journal of the American Society of Nephrology
Vol. 21, Issue 1
1 Jan 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Management of Symptomatic Carotid Stenosis in Individuals with CKD
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Management of Symptomatic Carotid Stenosis in Individuals with CKD
Rebecca F. Gottesman, Stephen M. Sozio
JASN Jan 2010, 21 (1) 9-11; DOI: 10.1681/ASN.2009111126

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Management of Symptomatic Carotid Stenosis in Individuals with CKD
Rebecca F. Gottesman, Stephen M. Sozio
JASN Jan 2010, 21 (1) 9-11; DOI: 10.1681/ASN.2009111126
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Disclosures
    • Footnotes
    • References
  • Info & Metrics
  • View PDF

More in this TOC Section

UP FRONT MATTERS

  • COVID-19 and APOL1: Understanding Disease Mechanisms through Clinical Observation
  • The Aftermath of AKI: Recurrent AKI, Acute Kidney Disease, and CKD Progression
  • Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases
Show more UP FRONT MATTERS

Editorials

  • Missing Self and DSA—Synergy of Two NK Cell Activation Pathways in Kidney Transplantation
  • Animal Model of Pregnancy after Acute Kidney Injury Mirrors the Human Observations
  • Will Targeting Interleukin-6 in the Anemia of CKD Change Our Treatment Paradigm?
Show more Editorials

Cited By...

  • Forty Years of Progress in Stroke
  • Google Scholar

Similar Articles

Related Articles

  • Carotid Endarterectomy Benefits Patients with CKD and Symptomatic High-Grade Stenosis
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire